Hair Dye Cancer Lawsuit: Bladder Cancer Claims by Hairstylists

The plaintiffs are mostly longtime salon professionals. They say that years of mixing and applying permanent hair color exposed them, through skin contact and inhalation, to chemicals such as aromatic amines including 4-aminobiphenyl (4-ABP) and ortho-toluidine, along with formaldehyde, and that this exposure caused their bladder cancer. They claim the manufacturers knew about the risk and did not warn salon workers, even ones who wore gloves.

Examples reported in the coverage include:

• A career cosmetologist, Beatrice Singleton, who filed in Los Angeles Superior Court in late April 2025 after about 40 years of exposure to hair dyes.
• Hector Corvera, a hairdresser whose petition led to the coordination of the California cases.
• Christy Esparza and Carl Kimbley, career cosmetologists who each sued John Paul Mitchell Systems in Los Angeles Superior Court on August 1, 2025 over Paul Mitchell Color XG hair dye.
• Other cosmetologist suits naming L'Oreal and Redken products.

These are mass tort claims: each plaintiff must prove her own exposure and diagnosis. The defendants deny that their dyes cause cancer, and no court or jury has ruled on that question.

The strongest evidence concerns occupational exposure. The National Cancer Institute reports that in 2010 the International Agency for Research on Cancer (IARC) concluded that some chemicals professional hairdressers are exposed to are "probably carcinogenic to humans," based on studies showing more bladder cancer among hairdressers and barbers. A 2010 meta-analysis of 42 studies found that people who had worked as hairdressers for at least 10 years were nearly twice as likely to develop bladder cancer.

For personal use, the picture is mixed. NCI summarizes a large U.S. cohort (the NIEHS Sister Study) in which Black women who used hair dye were 1.45 times as likely to develop breast cancer as non-users, compared with 1.07 times for non-Hispanic White women. Studies of personal dye use and bladder cancer have been less consistent, and dye formulations changed after regulators in the U.S. and Europe scrutinized older ingredients.

In California, Judge Samantha Jessner of the Los Angeles Superior Court issued an order on June 26, 2025 coordinating 12 related hair dye lawsuits for pretrial proceedings, in response to a petition by plaintiff Hector Corvera, and set a status conference for July 21, 2025. Additional cases have been filed since then.

Federal cases have also been filed, but they have not been centralized. As of September 2026, there is no federal MDL for hair dye cancer claims, which means cases move individually or through state coordination. This is separate from the hair relaxer MDL, which involves chemical straighteners and uterine cancer.

No trial date has been publicly confirmed, and no settlement has been announced. Early rulings on expert testimony will likely decide how far these cases go.

The early California cases came in quickly. Beatrice Singleton, a career cosmetologist, filed in late April 2025, citing about 40 years of exposure to popular hair dyes. At least 11 more suits followed in California state courts within about two months, each alleging that manufacturers failed to warn salon workers about bladder cancer risks, even for workers who wore gloves or took other precautions. On August 1, 2025, two more career cosmetologists, Christy Esparza and Carl Kimbley, each sued John Paul Mitchell Systems in Los Angeles Superior Court over Paul Mitchell Color XG, a color line widely used in professional salons. By then, reporting counted more than a dozen hair dye bladder cancer lawsuits against companies including L'Oreal, Redken, and Paul Mitchell.

NCI estimates that between 50% and 80% of women in the United States, Japan, and the European Union have used hair dye, which is why even a small effect on cancer risk would matter for public health, and why the outcome of these cases is being watched closely.

The attorneys bringing these cases generally look for:

• Long occupational exposure. Years of regular color services, often a decade or more, as a stylist, colorist, cosmetologist, or barber.
• A bladder cancer diagnosis. Some firms also review other cancers, but bladder cancer has the most support.
• Product identification. The professional color brands used at the salons where you worked.

Smoking is a major bladder cancer risk factor, and defendants will point to it. It does not automatically bar a claim, but it makes causation harder to prove. Home users with occasional dye use are unlikely to have a viable case. See class action vs. mass tort for why these cases are handled one person at a time.

What about people who are not stylists? Personal users who dyed their own hair for years and later developed cancer sometimes ask whether they can join. The current coordinated cases are built around occupational exposure, which involves far more contact than periodic personal use. NCI's review describes the evidence for personal use and bladder cancer as mixed, and the strongest personal-use signal it reports is for breast cancer among Black women. A personal user's case would likely be evaluated individually and would face a steeper causation hurdle. A 2014 pooled analysis of 17 studies found no increased bladder cancer risk from personal hair dye use, which defendants would cite in any such claim.

There are no verdicts or settlements in hair dye cancer litigation to point to, so any dollar figure would be speculation. In personal injury cases like these, damages can include medical bills, lost wages (important for stylists who could no longer work), pain and suffering, and, for families, wrongful death damages.

If the cases eventually settle as a group, mass tort settlements typically assign points based on diagnosis and stage, treatment (such as bladder removal), years of exposure, and competing risk factors. Salon workers who can document ten or more years of color work will generally have stronger claims, which tracks the ten-year threshold in the meta-analysis NCI cites.

Because none of these cases has reached trial, there is also no ruling yet on how damages would be measured for hair dye bladder cancer claims.

Timing is one of the biggest issues in hair dye cases, and it cuts in both directions.

According to the National Cancer Institute, permanent dyes make up about 80% of hair dye products on the market. They work by mixing colorless intermediates and couplers with hydrogen peroxide to form pigment inside the hair. Early permanent dyes used aromatic amines as intermediates, and some of those chemicals were reported to be carcinogenic. In the mid to late 1970s, manufacturers changed permanent dye formulas to eliminate some of those carcinogenic intermediates. NCI says it is not known whether any chemicals still used in hair dyes are carcinogenic.

That history shapes the evidence:

• A Swedish study of hairdressers across different time periods found no increased bladder cancer risk in recent decades, suggesting modern dyes without aromatic amines may not carry the same risk.
• A pooled analysis found that women who began using hair dye before 1980 had a higher non-Hodgkin lymphoma risk, while women who began after 1980 did not.
• For personal use overall, IARC classifies hair dye as "not classifiable" as to whether it causes cancer in humans, and a 2014 pooled analysis of 17 studies found no increased bladder cancer risk from personal use.

The plaintiffs in the current cases argue that modern professional color lines still expose stylists to aromatic amines such as 4-ABP and ortho-toluidine, and to formaldehyde, through skin contact and inhalation over thousands of services. The manufacturers point to the reformulation and the newer studies. Expect the dates of a stylist's career, and which products were used in which years, to be central in every case.

If you worked in salons before and after the 1970s changes, or across several decades, write down the years at each salon. That timeline will matter more than almost anything else in evaluating a claim.

People often confuse the two, but they are separate litigations with different products, injuries, and courts.

A stylist who both applied dye for years and personally used relaxers could, in principle, have claims in both tracks, but each requires its own diagnosis and proof. No settlement exists in either litigation as of September 2026.

Personal injury claims are governed by each state's statute of limitations, commonly two to three years. Many states start the clock when you knew or should have known your cancer might be linked to the product, which can be later than the diagnosis itself.

Because the lawsuits and publicity began in 2025, defendants may argue that salon workers diagnosed earlier should have investigated sooner. If you were diagnosed several years ago, talk to a lawyer promptly so the discovery rule can be evaluated for your state.

1. Gather your medical records, including pathology and treatment.
2. Reconstruct your work history: salons, years, and roughly how many color services you did per week.
3. List the color lines each salon used; former coworkers and salon owners can help.
4. Keep records of protective equipment you used or were not given.
5. Avoid anyone promising a specific payout. None exists.

Independent attorneys who handle occupational cancer cases can review your history and state deadline. A free case review takes about two minutes. Related pages: hair relaxer cancer lawsuits and shampoo hair loss lawsuits.